<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Appeal allowed: DTA clearances of vaccines under HSN 3002 treated as similar goods; FTP paras 6.8(a)/(k) and Notification No.23/2003-C.E. apply</title>
    <link>https://www.taxtmi.com/highlights?id=93596</link>
    <description>The CESTAT allowed the appeal, setting aside the impugned adjudication dated 18.02.2015 and quashing demands, penalty and confirmation of differential excise duty arising from DTA clearances by the 100% EOU. The Tribunal held that classification for excise, customs and FTP compliance follows the common eight-digit HSN-based commodity code (notably heading 3002 for the pharmaceutical products in issue), and the vaccines and formulations cleared to the DTA are &quot;similar goods&quot; for levy purposes. DTA clearances complied with FTP paras 6.8(a)/(k) and, where advances were accounted, were eligible for exemption under Notification No.23/2003-C.E.; the departmental treatment was legally unsustainable.</description>
    <language>en-us</language>
    <pubDate>Tue, 28 Oct 2025 08:33:52 +0530</pubDate>
    <lastBuildDate>Tue, 28 Oct 2025 08:33:53 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=860551" rel="self" type="application/rss+xml"/>
    <item>
      <title>Appeal allowed: DTA clearances of vaccines under HSN 3002 treated as similar goods; FTP paras 6.8(a)/(k) and Notification No.23/2003-C.E. apply</title>
      <link>https://www.taxtmi.com/highlights?id=93596</link>
      <description>The CESTAT allowed the appeal, setting aside the impugned adjudication dated 18.02.2015 and quashing demands, penalty and confirmation of differential excise duty arising from DTA clearances by the 100% EOU. The Tribunal held that classification for excise, customs and FTP compliance follows the common eight-digit HSN-based commodity code (notably heading 3002 for the pharmaceutical products in issue), and the vaccines and formulations cleared to the DTA are &quot;similar goods&quot; for levy purposes. DTA clearances complied with FTP paras 6.8(a)/(k) and, where advances were accounted, were eligible for exemption under Notification No.23/2003-C.E.; the departmental treatment was legally unsustainable.</description>
      <category>Highlights</category>
      <law>Central Excise</law>
      <pubDate>Tue, 28 Oct 2025 08:33:52 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=93596</guid>
    </item>
  </channel>
</rss>